_PRIVATE_LIMITED.webp)
Glopec International (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.42 M
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 9.23%
- Profit Growth 100.39%
- Ebitda 102.04%
- Net Worth 0.04%
- Total Assets 1.00%
About Glopec International (India)
Glopec International (India) Private Limited (GIIPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 November 2010 and has a history of 14 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.42 M, as per Ministry of Corporate Affairs (MCA) records.
Pritam Singh, Harcharan Singh, and Kashyap Shah serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51101TG2010PTC071300
-
Company No.
071300
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Nov 2010
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Glopec International (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pritam Singh
|
Director | 02-Apr-2012 | Current |
Harcharan Singh
|
Director | 22-Nov-2010 | Current |
|
Kashyap Shah
|
Director | 22-Nov-2010 | Current |
Financial Performance of Glopec International (India).
Glopec International (India) Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 9.23% increase. The company also saw a substantial improvement in profitability, with a 100.39% increase in profit. The company's net worth moved up by a moderate rise of 0.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glopec International (India)?
In 2019, Glopec International (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Leiutis Pharmaceuticals LlpHarcharan Singh is a mutual person
-
Biophore India Pharmaceuticals Private LimitedHarcharan Singh is a mutual person
-
Dhanvika Solvent Solutions Private LimitedKashyap Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Glopec International (India)?
Unlock and access historical data on people associated with Glopec International (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glopec International (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glopec International (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.